Spectral Announces Voting Results of Annual General and Special Meeting and Promotion of Chris Seto to Chief Operating Officer

TORONTO, June 05, 2020 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that, at the annual general and special meeting (the “Meeting”) of shareholders of the Company (“Shareholders”) that was held yesterday, all five nominees for the board of directors of the Company were elected, the voting results of which are as follows:
Full details of the foregoing and results of the Meeting are contained in the Report of Voting Results for the Meeting which will be filed on SEDAR at www.sedar.com.The Company understands that certain registered Shareholders were unable to log in to the virtual platform and ask questions. To the extent Shareholders have any questions for the Company, such Shareholders are invited to contact Chris Seto or Ali Mahdavi using the contact information provided below.The Company also announced that in addition to his role as Chief Financial Officer, Chris Seto has been appointed to Chief Operating Officer of Spectral.Dr. Paul Walker, Spectral’s President and Chief Executive Officer, commented, “I am very pleased today to announce that Chris Seto will assume the role of Chief Operating Officer as well as continuing in his current position as CFO for Spectral, effective immediately. This is a pivotal time for Spectral as we move forward to final development and commercialization of our products and we are making resource allocations to meet these new demands. Chris has already made significant contributions to Spectral’s financial outlook. He will now take over the day-to-day operations of the Company, and his management experience will further enhance our commercial operations.”About Spectral